465 related articles for article (PubMed ID: 17636039)
1. Characterization of the SOCS3 promoter response to prostaglandin E2 in T47D cells.
Barclay JL; Anderson ST; Waters MJ; Curlewis JD
Mol Endocrinol; 2007 Oct; 21(10):2516-28. PubMed ID: 17636039
[TBL] [Abstract][Full Text] [Related]
2. Regulation of suppressor of cytokine signaling 3 (SOC3) by growth hormone in pro-B cells.
Barclay JL; Anderson ST; Waters MJ; Curlewis JD
Mol Endocrinol; 2007 Oct; 21(10):2503-15. PubMed ID: 17609438
[TBL] [Abstract][Full Text] [Related]
3. SOCS3 as a tumor suppressor in breast cancer cells, and its regulation by PRL.
Barclay JL; Anderson ST; Waters MJ; Curlewis JD
Int J Cancer; 2009 Apr; 124(8):1756-66. PubMed ID: 19115200
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of prostaglandin E
Mukherjee S; Sengupta Bandyopadhyay S
Biochem J; 2018 Jan; 475(2):477-494. PubMed ID: 29269396
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 induces stromal cell-derived factor-1 expression in prostate stromal cells by activating protein kinase A and transcription factor Sp1.
Peng Y; Shi J; Du X; Wang L; Klocker H; Mo L; Mo Z; Zhang J
Int J Biochem Cell Biol; 2013 Mar; 45(3):521-30. PubMed ID: 23246486
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 activates cAMP response element-binding protein in glioma cells via a signaling pathway involving PKA-dependent inhibition of ERK.
Bidwell P; Joh K; Leaver HA; Rizzo MT
Prostaglandins Other Lipid Mediat; 2010 Feb; 91(1-2):18-29. PubMed ID: 20015475
[TBL] [Abstract][Full Text] [Related]
7. STAT3-mediated constitutive expression of SOCS3 in an undifferentiated rat trophoblast-like cell line.
Isobe A; Takeda T; Sakata M; Yamamoto T; Minekawa R; Hayashi M; Auernhammer CJ; Tasaka K; Murata Y
Placenta; 2006 Aug; 27(8):912-8. PubMed ID: 16300827
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 11 signaling components signal transducer and activator of transcription 3 (STAT3) and suppressor of cytokine signaling 3 (SOCS3) regulate human endometrial stromal cell differentiation.
Dimitriadis E; Stoikos C; Tan YL; Salamonsen LA
Endocrinology; 2006 Aug; 147(8):3809-17. PubMed ID: 16709613
[TBL] [Abstract][Full Text] [Related]
9. Silymarin suppresses the PGE2 -induced cell migration through inhibition of EP2 activation; G protein-dependent PKA-CREB and G protein-independent Src-STAT3 signal pathways.
Woo SM; Min KJ; Chae IG; Chun KS; Kwon TK
Mol Carcinog; 2015 Mar; 54(3):216-28. PubMed ID: 24127286
[TBL] [Abstract][Full Text] [Related]
10. Sp3 is involved in the regulation of SOCS3 gene expression.
Ehlting C; Häussinger D; Bode JG
Biochem J; 2005 May; 387(Pt 3):737-45. PubMed ID: 15554904
[TBL] [Abstract][Full Text] [Related]
11. Suppressor of Cytokine Signaling-3 (SOCS-3) Induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Expression in Hepatic HepG2 Cell Line.
Ruscica M; Ricci C; Macchi C; Magni P; Cristofani R; Liu J; Corsini A; Ferri N
J Biol Chem; 2016 Feb; 291(7):3508-19. PubMed ID: 26668321
[TBL] [Abstract][Full Text] [Related]
12. Mitogen-activated protein kinase and protein kinase A signaling pathways stimulate cholecystokinin transcription via activation of cyclic adenosine 3',5'-monophosphate response element-binding protein.
Hansen TV; Rehfeld JF; Nielsen FC
Mol Endocrinol; 1999 Mar; 13(3):466-75. PubMed ID: 10077003
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1.
Loeffler S; Fayard B; Weis J; Weissenberger J
Int J Cancer; 2005 Jun; 115(2):202-13. PubMed ID: 15688401
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin-E2 enhances EPO-mediated STAT5 transcriptional activity by serine phosphorylation of CREB.
Boer AK; Drayer AL; Rui H; Vellenga E
Blood; 2002 Jul; 100(2):467-73. PubMed ID: 12091337
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the preprotachykinin-I gene promoter through a protein kinase A-dependent, cyclic AMP response element-binding protein-independent mechanism.
Calin-Jageman IE; Wang J; Bannon MJ
J Neurochem; 2006 Apr; 97(1):255-64. PubMed ID: 16515544
[TBL] [Abstract][Full Text] [Related]
16. Flavanoids induce expression of the suppressor of cytokine signalling 3 (SOCS3) gene and suppress IL-6-activated signal transducer and activator of transcription 3 (STAT3) activation in vascular endothelial cells.
Wiejak J; Dunlop J; Mackay SP; Yarwood SJ
Biochem J; 2013 Sep; 454(2):283-93. PubMed ID: 23782265
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 inhibitor enhances whereas prostaglandin E2 inhibits the production of interferon-induced protein of 10 kDa in epidermoid carcinoma A431.
Kanda N; Watanabe S
J Invest Dermatol; 2002 Nov; 119(5):1080-9. PubMed ID: 12445196
[TBL] [Abstract][Full Text] [Related]
18. Induction of p21WAF1 expression via Sp1-binding sites by tamoxifen in estrogen receptor-negative lung cancer cells.
Lee TH; Chuang LY; Hung WC
Oncogene; 2000 Aug; 19(33):3766-73. PubMed ID: 10949931
[TBL] [Abstract][Full Text] [Related]
19. Suppressor of cytokine signalling-3 at pathological levels does not regulate lipopolysaccharide or interleukin-10 control of tumour necrosis factor-alpha production by human monocytes.
Prêle CM; Keith-Magee AL; Yerkovich ST; Murcha M; Hart PH
Immunology; 2006 Sep; 119(1):8-17. PubMed ID: 16925527
[TBL] [Abstract][Full Text] [Related]
20. PGE2 inhibits chondrocyte differentiation through PKA and PKC signaling.
Li TF; Zuscik MJ; Ionescu AM; Zhang X; Rosier RN; Schwarz EM; Drissi H; O'Keefe RJ
Exp Cell Res; 2004 Oct; 300(1):159-69. PubMed ID: 15383323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
